Pacer Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.88M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.65M | Sell |
|
|||||
|
2024
Q4 | $4.35M | Buy |
|
|||||
|
2024
Q3 | $3.32M | Sell |
|
|||||
|
2024
Q2 | $4.39M | Buy |
|
|||||
|
2024
Q1 | $2.5M | Buy |
|
|||||
|
2023
Q4 | $1.92M | Buy |
|
|||||
|
2023
Q3 | $918K | Sell |
|
|||||
|
2023
Q2 | $1.93M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.2M | Buy |
|
|||||
|
2022
Q3 | $447K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $927K | Sell |
|
|||||
|
2021
Q2 | $963K | Buy |
|
|||||
|
2021
Q1 | $78K | Sell |
|
|||||
|
2020
Q4 | $139K | Buy |
|
|||||
|
2020
Q3 | $88K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $327K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $149K | Sell |
|
|||||
|
2017
Q3 | $652K | Sell |
|
|||||
|
2017
Q2 | $505K | Buy |
|
|||||
|
2017
Q1 | $425K | Buy |
|
|||||
|
2016
Q4 | $311K | Buy |
|
|||||
|
2016
Q3 | $383K | Buy |
|
|||||
|
2016
Q2 | $284K | Buy |
|